Physician

Saurabh Ranjan Sinha, M.D.

According to 2025 Medicare claims, Saurabh Sinha, M.D. (NPI: 1043211212) practices epileptologists in the Philadelphia, PA market, with the plurality of this provider's patient population coming from Philadelphia, PA. This provider's primary affiliated billing organization is UNIVERSITY OF PENN-MEDICAL GROUP (NPI: 1164810271; TIN: 232743545) and primary practice location at 19104-4208. Sinha is affiliated with the Keystone ACO (ACO ID: A1552) and Penn Medicine Healthcare Partners, LLC (ACO ID: A5318), participating under the MSSP model.

Sinha's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 297 traditional Medicare patients, billed 871 HCPCS/CPT codes, and received $53,177 in Medicare payments. The top billing code was 95720 (Measurement of brain wave activity with video (veeg), 12-26 hours with review and report by health care professional). Part D data shows 1,312 prescription claims across 155 beneficiaries totaling $529,835 in drug costs, led by Epidiolex (Cannabidiol (Cbd)). Open Payments data shows 9 records totaling $654. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has declined steadily, from $74,091 to $53,177. Similarly, Part D prescription costs have fallen sharply in recent years, from $660,233 to $529,835. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	440	1,247	$74,091
2016	430	1,102	$80,558
2017	471	1,239	$87,875
2018	483	1,456	$108,433
2019	470	1,227	$82,693
2020	399	1,168	$73,416
2021	431	1,167	$73,335
2022	292	640	$48,402
2023	212	589	$41,500
2024	297	871	$53,177

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	188	1,981	$660,233
2016	201	2,393	$774,933
2017	239	2,946	$1,030,798
2018	231	2,703	$1,103,126
2019	220	2,564	$1,164,210
2020	210	2,417	$1,258,032
2021	217	2,323	$1,392,789
2022	204	1,692	$974,346
2023	149	888	$380,527
2024	155	1,312	$529,835

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

No connected DME records

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
95720	Measurement of brain wave activity with video (veeg), 12-26 hours with review and report by health care professional	63	110	$165
95718	Measurement of brain wave activity with video (veeg), 2-12 hours with review and report by health care professional	39	43	$105
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	33	37	$65
95816	Measurement of brain wave activity (eeg), awake and drowsy	63	63	$44
G2211	Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's	72	84	$12

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Epidiolex	Cannabidiol (Cbd)	31	1,064	$108,415
Fycompa	Perampanel	32	1,323	$65,348
Briviact	Brivaracetam	33	1,350	$63,058
Zonegran	Zonisamide	26	912	$48,857
Xcopri	Cenobamate	31	982	$43,222

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	9	$654	JAZZ PHARMACEUTICALS INC.
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Saurabh Ranjan Sinha, M.D.?

Tedicare shows public-source Medicare data for Saurabh Ranjan Sinha, M.D. (NPI 1043211212), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Saurabh Ranjan Sinha, M.D. have ACO affiliation data?

Saurabh Ranjan Sinha, M.D. is shown with ACO affiliation data for Keystone ACO (MSSP, ACO ID A1552) and Penn Medicine Healthcare Partners, LLC (MSSP, ACO ID A5318).

What billing organization is linked to Saurabh Ranjan Sinha, M.D.?

Saurabh Ranjan Sinha, M.D. is linked to UNIVERSITY OF PENN-MEDICAL GROUP (billing NPI 1164810271) in the available physician profile data.

Does Saurabh Ranjan Sinha, M.D. have Open Payments data?

Saurabh Ranjan Sinha, M.D. has 9 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.